Fig. 2From: Higher dose alglucosidase alfa is associated with improved overall survival in infantile-onset Pompe disease (IOPD): data from the Pompe RegistryChanging trends in clinical practice: alglucosidase alfa dose over time by year of first treatmentBack to article page